183 related articles for article (PubMed ID: 8383879)
1. Deficiency in rhabdomyosarcomas of a factor required for MyoD activity and myogenesis.
Tapscott SJ; Thayer MJ; Weintraub H
Science; 1993 Mar; 259(5100):1450-3. PubMed ID: 8383879
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional activation domain of the muscle-specific gene-regulatory protein myf5.
Braun T; Winter B; Bober E; Arnold HH
Nature; 1990 Aug; 346(6285):663-5. PubMed ID: 2385294
[TBL] [Abstract][Full Text] [Related]
3. Comparison of genome-wide binding of MyoD in normal human myogenic cells and rhabdomyosarcomas identifies regional and local suppression of promyogenic transcription factors.
MacQuarrie KL; Yao Z; Fong AP; Diede SJ; Rudzinski ER; Hawkins DS; Tapscott SJ
Mol Cell Biol; 2013 Feb; 33(4):773-84. PubMed ID: 23230269
[TBL] [Abstract][Full Text] [Related]
4. Regulatory elements that control the lineage-specific expression of myoD.
Goldhamer DJ; Faerman A; Shani M; Emerson CP
Science; 1992 Apr; 256(5056):538-42. PubMed ID: 1315077
[TBL] [Abstract][Full Text] [Related]
5. Repression of c-fos promoter by MyoD on muscle cell differentiation.
Trouche D; Grigoriev M; Lenormand JL; Robin P; Leibovitch SA; Sassone-Corsi P; Harel-Bellan A
Nature; 1993 May; 363(6424):79-82. PubMed ID: 8386804
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional activation of the myogenin gene by MEF2-mediated recruitment of myf5 is inhibited by adenovirus E1A protein.
Johanson M; Meents H; Ragge K; Buchberger A; Arnold HH; Sandmöller A
Biochem Biophys Res Commun; 1999 Nov; 265(1):222-32. PubMed ID: 10548518
[TBL] [Abstract][Full Text] [Related]
7. Mutation of Thr115 in MyoD positively regulates function in murine fibroblasts and human rhabdomyosarcoma cells.
Liu LN; Dias P; Houghton PJ
Cell Growth Differ; 1998 Sep; 9(9):699-711. PubMed ID: 9751114
[TBL] [Abstract][Full Text] [Related]
8. DNA binding and transcriptional regulatory activity of mammalian achaete-scute homologous (MASH) proteins revealed by interaction with a muscle-specific enhancer.
Johnson JE; Birren SJ; Saito T; Anderson DJ
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3596-600. PubMed ID: 1314394
[TBL] [Abstract][Full Text] [Related]
9. Rhabdomyosarcomas do not contain mutations in the DNA binding domains of myogenic transcription factors.
Anand G; Shapiro DN; Dickman PS; Prochownik EV
J Clin Invest; 1994 Jan; 93(1):5-9. PubMed ID: 8282820
[TBL] [Abstract][Full Text] [Related]
10. Cell-cell interaction modulates myoD-induced skeletal myogenesis of pluripotent P19 cells in vitro.
Armour C; Garson K; McBurney MW
Exp Cell Res; 1999 Aug; 251(1):79-91. PubMed ID: 10438573
[TBL] [Abstract][Full Text] [Related]
11. Paired MyoD-binding sites regulate myosin light chain gene expression.
Wentworth BM; Donoghue M; Engert JC; Berglund EB; Rosenthal N
Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1242-6. PubMed ID: 1847512
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acid induces myogenin synthesis and myogenic differentiation in the rat rhabdomyosarcoma cell line BA-Han-1C.
Arnold HH; Gerharz CD; Gabbert HE; Salminen A
J Cell Biol; 1992 Aug; 118(4):877-87. PubMed ID: 1323566
[TBL] [Abstract][Full Text] [Related]
13. Activation of fgf4 gene expression in the myotomes is regulated by myogenic bHLH factors and by sonic hedgehog.
Fraidenraich D; Iwahori A; Rudnicki M; Basilico C
Dev Biol; 2000 Sep; 225(2):392-406. PubMed ID: 10985858
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of protein phosphatases blocks myogenesis by first altering MyoD binding activity.
Kim SJ; Kim KY; Tapscott SJ; Winokur TS; Park K; Fujiki H; Weintraub H; Roberts AB
J Biol Chem; 1992 Jul; 267(21):15140-5. PubMed ID: 1321827
[TBL] [Abstract][Full Text] [Related]
15. The basic helix-loop-helix transcription factor Mist1 functions as a transcriptional repressor of myoD.
Lemercier C; To RQ; Carrasco RA; Konieczny SF
EMBO J; 1998 Mar; 17(5):1412-22. PubMed ID: 9482738
[TBL] [Abstract][Full Text] [Related]
16. Transactivation of cardiac MLC-2 promoter by MyoD in 10T1/2 fibroblast cells is independent of E-box requirement but depends upon new proteins that recognize MEF-2 site.
Goswami SK; Siddiqui MA
Cell Mol Biol Res; 1995; 41(3):199-205. PubMed ID: 8589760
[TBL] [Abstract][Full Text] [Related]
17. Acquisition of myogenic specificity by replacement of three amino acid residues from MyoD into E12.
Davis RL; Weintraub H
Science; 1992 May; 256(5059):1027-30. PubMed ID: 1317057
[TBL] [Abstract][Full Text] [Related]
18. Failure of Myf5 to support myogenic differentiation without myogenin, MyoD, and MRF4.
Valdez MR; Richardson JA; Klein WH; Olson EN
Dev Biol; 2000 Mar; 219(2):287-98. PubMed ID: 10694423
[TBL] [Abstract][Full Text] [Related]
19. Amplification of MDM2 inhibits MyoD-mediated myogenesis.
Fiddler TA; Smith L; Tapscott SJ; Thayer MJ
Mol Cell Biol; 1996 Sep; 16(9):5048-57. PubMed ID: 8756663
[TBL] [Abstract][Full Text] [Related]
20. E47 phosphorylation by p38 MAPK promotes MyoD/E47 association and muscle-specific gene transcription.
Lluís F; Ballestar E; Suelves M; Esteller M; Muñoz-Cánoves P
EMBO J; 2005 Mar; 24(5):974-84. PubMed ID: 15719023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
